Abstract:  

To rapidly characterize the virological properties of emerging SARS-CoV-2 variants, I established the Genotype to Phenotype Japan (G2P-Japan) Consortium. Working alongside my colleagues in G2P-Japan, we have analyzed and identified key virological features of these variants. In this talk, I will provide a brief overview of our consortium’s research activities and explore opportunities for international collaboration to address future outbreaks and pandemics.

Recommended readings: 

1. Nature: Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
2. Nature: Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
3. EBioMedicine: Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236